StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) stock

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.28−0.00 (-0.74%)

Close on Nov 17, 2026Market cap $53.58MP/E –Yield –

Heron Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Heron Therapeutics's price to book ratio was 9.6× on Nov 11, 2026, against 13.1× a year earlier. Over the last 5 years it ranged from 2.6× to 21.0×, with a median of 6.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.6×−5.1
2025Dec 31, 202514.7×−6.3
2023Apr 28, 202321.0×+15.0
2022Apr 29, 20225.9×−1.4
2021Dec 31, 20217.4×+0.5
2020Dec 31, 20206.9×+0.4
2019Dec 31, 20196.5×+2.2
2018Dec 31, 20184.3×−18.0
2017Dec 29, 201722.3×−4.8
2016Dec 30, 201627.2×+21.3
2015Dec 31, 20155.9×+2.9
2014Dec 31, 20143.0×−3.6
2013Dec 31, 20136.6×+1.2
2012Apr 30, 20125.3×−5.6
2011Jul 29, 201111.0×–

More Heron Therapeutics figures

See a number that looks wrong?